Zambia Infant Cohort Study - Brains Optimized for Surviving & Thriving

Status Active, not recruiting

Clinical Trial Summary

Children exposed to HIV in-utero but uninfected (CHEUs) number 14.8 million globally. In Zambia, an estimated 56,000 CHEUs are born annually, a staggering fraction of the national birth cohort. Multiple studies establish that CHEUs are more neurodevelopmentally vulnerable than HIV-unexposed peers. In Zambia, there are existing effective early childhood developmental (ECD) interventions that target other vulnerable populations, but never trialed specifically for CHEUs. Scaling up ECD is now a priority of Zambia's national strategy, but CHEUs are not currently targeted. There is a need to better understand the scope and mechanism of CHEU-related neurodevelopmental differences and what interventions are most effective. This randomized clinical trial (RCT) is a true effectiveness trial as the intervention will deploy a home-based adaptation of the same curriculum that is currently used elsewhere in the country, named Scaling Up Early Childhood Development In Zambia (SUPERCDZ). The effectiveness of a scalable early childhood development (ECD) intervention for CHEUs will be evaluated using normalized Z-scores of neurodevelopmental testing at age 24 months. In this RCT the investigators will test the following hypotheses: Hypothesis 1: An ECD intervention delivered by community health workers via bi-weekly home visits will improve neurodevelopmental outcomes in CHEUs. Hypothesis 2: CHEUs have significantly worse neurodevelopmental outcomes than unexposed peers at 24 months, mediated by preterm birth, disease stage or antiretroviral (ARV) exposure. This RCT will build on an existent, actively recruiting cohort of 1500 pregnant women-infant dyads in a peri-urban hospital in Zambia, the Zambian Infant Cohort Study (ZICS), by extending the follow-up of a subsample of infants from 6 months to 2 years amongst the last 525 children enrolled (ZICS-BOOST- Brains Optimized to Survive and Thrive). The study will have three arms: Arm 1) CHEU + ECD intervention (n=175); Arm 2) CHEU without ECD intervention (n=175); Arm 3) HUU without intervention (n=175).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Child Development

Clinical Trial Details

NCT number	NCT05119959
Study type	Interventional
Source	Boston University
Contact
Status	Active, not recruiting
Phase	N/A
Start date	April 14, 2022
Completion date	October 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT06315036` - Effects of Developmental Gymnastics on Preschoolers' Motor Skills	N/A
Active, not recruiting	`NCT05143294` - Conectar Jugando: Board Games in Elementary Classrooms (6-12 Years Old) to Improve Executive Functions	N/A
Completed	`NCT05267730` - Conectar Jugando: Board Games in Rural Elementary Classrooms (6-12 Years Old) to Improve Executive Functions	N/A
Completed	`NCT03680157` - Comparing Rater Reliability of Familiar Practitioners to Blinded Coders
Completed	`NCT00362076` - The Role of Motion in Infants' Ability to Categorize	N/A
Recruiting	`NCT05525962` - Vulnerability/Resilience Factors Influencing the Developmental Trajectories and Adaptive Methods of Children and Adolescents in Child Welfare System.
Completed	`NCT03232606` - Physical Activity of Asthmatic Children
Completed	`NCT05955755` - The Effect of Butterfly Vacuum Blood Collection Set and Standard Vacutanier Needle on the Level of Pain and Fear	N/A
Recruiting	`NCT04443855` - WASH Benefits Child Development Follow up	N/A
Not yet recruiting	`NCT06335524` - Infant-Maternal Partnership and Cognitive Training Study for Preterm Infants	N/A
Not yet recruiting	`NCT05783141` - Prebiotic Effects in Healthy Toddlers	N/A
Completed	`NCT02800616` - The Healthy Elementary School of the Future	N/A
Completed	`NCT02539251` - Arabic Ages and Stages Questionnaire-III
Completed	`NCT02451059` - Reducing Socioeconomic Disparities in Health at Pediatric Visits	N/A
Completed	`NCT02242539` - Tools to Improve Parental Recognition of Developmental Deficits in Children	N/A
Completed	`NCT03010306` - CASITA Intervention for Children at Risk of Delay in Carabayllo, Peru	N/A
Completed	`NCT01683565` - Preemie Tots: A Pilot Study to Understand the Effects of Prematurity in Toddlerhood	Phase 4
Completed	`NCT00989859` - Photo-Plethysmographic Camera to Monitor Heart Rate, Respiration Rate and Oxygen Saturation in Infants
Recruiting	`NCT00980733` - Efficacy of Micronutrient Fortified Yoghurt in School Children for Health Benefits	Phase 3
Terminated	`NCT04347707` - Building Regulation in Dual Generations	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Zambia Infant Cohort Study - Brains Optimized for Surviving and Thriving — ZICS-BOOST

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms